◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

TENNOR THERAP-B (6872) Financial History

Name: TENNOR THERAP-B (6872) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-08-10

TENNOR THERAP-B (6872) operates in the Biotechnology industry and is headquartered in Suzhou, China. Its market capitalization is roughly HKD 10 billion. In the fiscal year ended 2025-12-31, 6872 reported HKD 0M in revenue and (HKD 153M) in net income.

TenNor Therapeutics (Suzhou) Limited engages in discovery, development and commercialization of differentiated therapies for diseases associated with bacterial infections and bacterial metabolism.

Interactive charts & full statements →

6872 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31
Total Revenue	HKD 0M	HKD 0M	HKD 0M
Operating Income (EBIT)	(HKD 101M)	(HKD 78M)	(HKD 123M)
Net Income	(HKD 153M)	(HKD 146M)	(HKD 192M)

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

6872 Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2025-12-31	2024-12-31
Total Revenue	HKD 0M	HKD 0M
Operating Income (EBIT)	(HKD 20M)	(HKD 34M)
Net Income	(HKD 38M)	(HKD 58M)

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

6872 Free Cash Flow History

6872 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31
Total Assets	HKD 227M	HKD 133M	HKD 96M
Total Liabilities	HKD 73M	HKD 1.0B	HKD 855M

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6872 viewer.

Other Companies in Biotechnology

2595 · GenFleet Therapeutics (Shanghai) Inc. — $11 billion
1672 · Ascletis Pharma Inc. — $11 billion
4875 · MediciNova, Inc. — $10 billion
2493 · MABWELL-B — $10 billion
NUVL · Nuvalent Inc — $10 billion
1779 · LONGBIO-B — $10 billion
ABVX · ABIVAX Société Anonyme — $9 billion
6938 · Suzhou Ribo Life Science Co — $9 billion

← 6871 All “0-9” companies 6874 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.